Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 124

1.

The prevalence of oesophagitis in "silent" gastro-oesophageal reflux disease: Higher than expected?

Zerbib F.

Dig Liver Dis. 2014 Nov 8. pii: S1590-8658(14)00730-0. doi: 10.1016/j.dld.2014.10.006. [Epub ahead of print] No abstract available.

PMID:
25458778
[PubMed - as supplied by publisher]
2.

Oesophageal dysphagia: manifestations and diagnosis.

Zerbib F, Omari T.

Nat Rev Gastroenterol Hepatol. 2014 Nov 18. doi: 10.1038/nrgastro.2014.195. [Epub ahead of print] Review.

PMID:
25404278
[PubMed - as supplied by publisher]
3.

Olmesartan-associated enteropathy: results of a national survey.

Marthey L, Cadiot G, Seksik P, Pouderoux P, Lacroute J, Skinazi F, Mesnard B, Chayvialle JA, Savoye G, Druez A, Parlier D, Abitbol V, Gompel M, Eoche M, Poncin E, Bobichon R, Colardelle P, Wils P, Salloum H, Peschard S, Zerbib F, Méresse B, Cerf-Bensussan N, Malamut G, Carbonnel F.

Aliment Pharmacol Ther. 2014 Nov;40(9):1103-9. doi: 10.1111/apt.12937. Epub 2014 Sep 9.

PMID:
25199794
[PubMed - in process]
4.

Inter-observer agreement for diagnostic classification of esophageal motility disorders defined in high-resolution manometry.

Fox MR, Pandolfino JE, Sweis R, Sauter M, Abreu Y Abreu AT, Anggiansah A, Bogte A, Bredenoord AJ, Dengler W, Elvevi A, Fruehauf H, Gellersen S, Ghosh S, Gyawali CP, Heinrich H, Hemmink M, Jafari J, Kaufman E, Kessing K, Kwiatek M, Lubomyr B, Banasiuk M, Mion F, Pérez-de-la-Serna J, Remes-Troche JM, Rohof W, Roman S, Ruiz-de-León A, Tutuian R, Uscinowicz M, Valdovinos MA, Vardar R, Velosa M, Waśko-Czopnik D, Weijenborg P, Wilshire C, Wright J, Zerbib F, Menne D.

Dis Esophagus. 2014 Sep 3. doi: 10.1111/dote.12278. [Epub ahead of print]

PMID:
25185507
[PubMed - as supplied by publisher]
5.

Pharyngeal pH alone is not reliable for the detection of pharyngeal reflux events: A study with oesophageal and pharyngeal pH-impedance monitoring.

Desjardin M, Roman S, des Varannes SB, Gourcerol G, Coffin B, Ropert A, Mion F, Zerbib F.

United European Gastroenterol J. 2013 Dec;1(6):438-44. doi: 10.1177/2050640613513016.

PMID:
24917995
[PubMed]
Free PMC Article
6.

Treatment of GORD: Three decades of progress and disappointments.

Galmiche JP, Zerbib F, des Varannes SB.

United European Gastroenterol J. 2013 Jun;1(3):140-50. doi: 10.1177/2050640613484021.

PMID:
24917952
[PubMed]
Free PMC Article
7.

Risk of new or recurrent cancer under immunosuppressive therapy in patients with IBD and previous cancer.

Beaugerie L, Carrat F, Colombel JF, Bouvier AM, Sokol H, Babouri A, Carbonnel F, Laharie D, Faucheron JL, Simon T, de Gramont A, Peyrin-Biroulet L; CESAME Study Group.

Gut. 2014 Sep;63(9):1416-23. doi: 10.1136/gutjnl-2013-305763. Epub 2013 Oct 25.

PMID:
24162591
[PubMed - indexed for MEDLINE]
8.

Functional testing: pharyngeal pH monitoring and high-resolution manometry.

Savarino E, Zentilin P, Savarino V, Tenca A, Penagini R, Clarke JO, Bravi I, Zerbib F, Yüksel ES.

Ann N Y Acad Sci. 2013 Oct;1300:226-35. doi: 10.1111/nyas.12255. Review.

PMID:
24117645
[PubMed - indexed for MEDLINE]
9.

Endotherapy for and tailored approaches to treating GERD, and refractory GERD.

Locke GR 3rd, Horwhat J, Mashimo H, Savarino E, Zentilin P, Savarino V, Zerbib F, Armbruster SP, Wong RK, Moawad F.

Ann N Y Acad Sci. 2013 Oct;1300:166-86. doi: 10.1111/nyas.12240. Review.

PMID:
24117641
[PubMed - indexed for MEDLINE]
10.

Innovative techniques in evaluating the esophagus; imaging of esophageal morphology and function; and drugs for esophageal disease.

Neumann H, Neurath MF, Vieth M, Lever FM, Meijer GJ, Lips IM, McMahon BP, Ruurda JP, van Hillegersberg R, Siersema P, Levine MS, Scharitzer M, Pokieser P, Zerbib F, Savarino V, Zentilin P, Savarino E, Chan WW.

Ann N Y Acad Sci. 2013 Oct;1300:11-28. doi: 10.1111/nyas.12233. Review.

PMID:
24117631
[PubMed - indexed for MEDLINE]
11.

Vedolizumab as induction and maintenance therapy for Crohn's disease.

Sandborn WJ, Feagan BG, Rutgeerts P, Hanauer S, Colombel JF, Sands BE, Lukas M, Fedorak RN, Lee S, Bressler B, Fox I, Rosario M, Sankoh S, Xu J, Stephens K, Milch C, Parikh A; GEMINI 2 Study Group.

N Engl J Med. 2013 Aug 22;369(8):711-21. doi: 10.1056/NEJMoa1215739.

PMID:
23964933
[PubMed - indexed for MEDLINE]
Free Article
12.

Early administration of azathioprine vs conventional management of Crohn's Disease: a randomized controlled trial.

Cosnes J, Bourrier A, Laharie D, Nahon S, Bouhnik Y, Carbonnel F, Allez M, Dupas JL, Reimund JM, Savoye G, Jouet P, Moreau J, Mary JY, Colombel JF; Groupe d'Etude Thérapeutique des Affections Inflammatoires du Tube Digestif (GETAID).

Gastroenterology. 2013 Oct;145(4):758-65.e2; quiz e14-5. doi: 10.1053/j.gastro.2013.04.048. Epub 2013 Apr 30.

PMID:
23644079
[PubMed - indexed for MEDLINE]
13.

Control of AA amyloidosis complicating Crohn's disease: a clinico-pathological study.

Denis MA, Cosyns JP, Persu A, Dewit O, de Galocsy C, Hoang P, Maldague P, Wallemacq P, Zerbib F, Fiasse R.

Eur J Clin Invest. 2013 Mar;43(3):292-301. doi: 10.1111/eci.12045. Epub 2013 Feb 4.

PMID:
23373823
[PubMed - indexed for MEDLINE]
14.

Modern medical and surgical management of difficult-to-treat GORD.

Zerbib F, Sifrim D, Tutuian R, Attwood S, Lundell L.

United European Gastroenterol J. 2013 Feb;1(1):21-31. doi: 10.1177/2050640612473964.

PMID:
24917938
[PubMed]
Free PMC Article
15.

Comparative evaluation of 29 commercial Helicobacter pylori serological kits.

Burucoa C, Delchier JC, Courillon-Mallet A, de Korwin JD, Mégraud F, Zerbib F, Raymond J, Fauchère JL.

Helicobacter. 2013 Jun;18(3):169-79. doi: 10.1111/hel.12030. Epub 2013 Jan 14.

PMID:
23316886
[PubMed - indexed for MEDLINE]
16.

Development of esophageal adenocarcinoma on buried glands following radiofrequency ablation for Barrett's esophagus.

Chabrun E, Marty M, Zerbib F.

Endoscopy. 2012;44 Suppl 2 UCTN:E392. doi: 10.1055/s-0032-1310245. Epub 2012 Nov 8. No abstract available.

PMID:
23139037
[PubMed - indexed for MEDLINE]
17.

Normal values of pharyngeal and esophageal 24-hour pH impedance in individuals on and off therapy and interobserver reproducibility.

Zerbib F, Roman S, Bruley Des Varannes S, Gourcerol G, Coffin B, Ropert A, Lepicard P, Mion F; Groupe Français De Neuro-Gastroentérologie.

Clin Gastroenterol Hepatol. 2013 Apr;11(4):366-72. doi: 10.1016/j.cgh.2012.10.041. Epub 2012 Nov 8.

PMID:
23142603
[PubMed - indexed for MEDLINE]
18.

Novel therapeutics for gastro-esophageal reflux symptoms.

Zerbib F, Simon M.

Expert Rev Clin Pharmacol. 2012 Sep;5(5):533-41. doi: 10.1586/ecp.12.38. Review.

PMID:
23121276
[PubMed - indexed for MEDLINE]
19.

[Proton pump inhibitors in gastro-oesophageal reflux disease: what is the further step?].

Simon M, Zerbib F.

Presse Med. 2013 Jul-Aug;42(7-8):1081-4. doi: 10.1016/j.lpm.2012.09.002. Epub 2012 Oct 15. French.

PMID:
23079391
[PubMed - indexed for MEDLINE]
20.

Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial.

Laharie D, Bourreille A, Branche J, Allez M, Bouhnik Y, Filippi J, Zerbib F, Savoye G, Nachury M, Moreau J, Delchier JC, Cosnes J, Ricart E, Dewit O, Lopez-Sanroman A, Dupas JL, Carbonnel F, Bommelaer G, Coffin B, Roblin X, Van Assche G, Esteve M, Färkkilä M, Gisbert JP, Marteau P, Nahon S, de Vos M, Franchimont D, Mary JY, Colombel JF, Lémann M; Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives.

Lancet. 2012 Dec 1;380(9857):1909-15. doi: 10.1016/S0140-6736(12)61084-8. Epub 2012 Oct 10.

PMID:
23063316
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk